Bristol Myers Squibb (BMY) is a publicly traded Healthcare sector company. As of May 20, 2026, BMY trades at $58.54 with a market cap of $117.03B and a P/E ratio of 16.73. BMY moved +0.32% today. Year to date, BMY is +9.07%; over the trailing twelve months it is +23.49%. Its 52-week range spans $42.52 to $63.33. Analyst consensus is buy with an average price target of $64.29. Rallies surfaces BMY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bristol Myers Squibb (BMY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BMY moved +0.32% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $58.54 |
| Market Cap | $117.03B |
| P/E Ratio | 16.73 |
| EPS | $3.47 |
| Dividend Yield | 0.63% |
| 52-Week High | $63.33 |
| 52-Week Low | $42.52 |
| Volume | 2.87M |
| Avg Volume | 0 |
| Revenue (TTM) | $48.19B |
| Net Income | $7.05B |
| Gross Margin | 71.08% |
18 analysts cover BMY: 0 strong buy, 6 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $64.29.